Gradient Health vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 36)
Gradient Health logo

Gradient Health

EmergingHealthcare

Medical Imaging AI Data

Gradient Health provides a medical imaging data platform giving AI researchers and healthcare companies access to de-identified radiology datasets for model training and validation.

AI VisibilityBeta
Overall Score
D36
Category Rank
#531 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
41
Perplexity
31
Gemini
36

About

Gradient Health is a healthcare data company founded in 2019 that operates a platform providing access to de-identified medical imaging data for AI development, research, and regulatory validation. The company partners with health systems and imaging centers to source, de-identify, and structure radiology datasets including X-rays, CT scans, MRI studies, and pathology images that AI developers need to train and validate clinical algorithms. Obtaining sufficient high-quality labeled medical imaging data has been one of the primary bottlenecks for AI medical imaging companies, and Gradient Health addresses this by creating a market for compliant data access. The company uses advanced de-identification techniques that go beyond HIPAA minimum requirements to ensure patient privacy while preserving the clinical detail that makes datasets useful for AI training. Gradient serves medical imaging AI companies, pharmaceutical companies conducting imaging biomarker research, and academic medical centers building AI models. The company has built relationships with health systems across the US and has assembled imaging datasets spanning millions of studies across diverse patient populations and imaging equipment types.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

36
Overall Score
88
#531
Category Rank
#3
72
AI Consensus
78
stable
Trend
stable
41
ChatGPT
83
31
Perplexity
87
36
Gemini
85
31
Claude
90
39
Grok
92

Key Details

Category
Medical Imaging AI Data
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Gradient Health
Medical Imaging AI Data
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.